{"id":192152,"date":"2026-10-01T15:20:54","date_gmt":"2026-10-01T13:20:54","guid":{"rendered":"https:\/\/www.bcfi.be\/?post_type=avada_portfolio&#038;p=192152"},"modified":"2026-10-01T15:24:39","modified_gmt":"2026-10-01T13:24:39","slug":"mdr1-p-gp-et-interactions-medicamenteuses-chez-le-chien-et-le-chat-folia-quiz","status":"publish","type":"avada_portfolio","link":"https:\/\/cbip.be\/fr\/portfolio\/mdr1-p-gp-et-interactions-medicamenteuses-chez-le-chien-et-le-chat-folia-quiz\/","title":{"rendered":"MDR1, P-gp et interactions m\u00e9dicamenteuses chez le chien et le chat \u2013 Folia Quiz"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\"><p>Quel est le lien entre g\u00e8ne MDR1 et interactions m\u00e9dicamenteuses ? Une prot\u00e9ine transmembranaire appel\u00e9e glycoprot\u00e9ine P (P-gp), qui joue un r\u00f4le de protection vis-\u00e0-vis de certaines toxines. En cas de mutation g\u00e9n\u00e9tique ou d\u2019interactions m\u00e9dicamenteuses, son fonctionnement peut en \u00eatre alt\u00e9r\u00e9.<\/p>\n<p>Quelles en sont les implications pharmacoth\u00e9rapeutiques chez le chien ? Quelles sont les mol\u00e9cules concern\u00e9es ? Et qu\u2019en est-il du chat ?<\/p>\n<p>A partir de quelques cas pratiques, dix questions vous seront pos\u00e9es et vous permettront de tester vos connaissances sur le g\u00e8ne MDR1, la P-gp et les interactions m\u00e9dicamenteuses susceptibles d\u2019\u00eatre observ\u00e9es chez le chien et le chat.<\/p>\n<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>&#9201; <b>XL &#8211; 1 heure<\/b><br \/>Quel est le lien entre g\u00e8ne MDR1 et interactions m\u00e9dicamenteuses ? Pourquoi faut-il en tenir compte pour certains traitements chez le chien ? Et qu\u2019en est-il du chat ? \u00ab\u00a0<br \/><b> V\u00e9t\u00e9rinaire: 2 PFCC (CRFOMV), V\u00e9t\u00e9rinaire: en attente (NGROD)<\/b><br \/>&#9202; septembre 2026<\/p>\n","protected":false},"author":3,"featured_media":192154,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","format":"standard","meta":{"footnotes":""},"portfolio_category":[172],"portfolio_skills":[20306,207],"portfolio_tags":[],"class_list":["post-192152","avada_portfolio","type-avada_portfolio","status-publish","format-standard","has-post-thumbnail","hentry","portfolio_category-pour-les-veterinaires","portfolio_skills-veterinaire-2-pfcc-ngrod","portfolio_skills-veterinaire-demande-en-cours-crfomv"],"_links":{"self":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/avada_portfolio\/192152","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/avada_portfolio"}],"about":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/types\/avada_portfolio"}],"author":[{"embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/comments?post=192152"}],"version-history":[{"count":4,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/avada_portfolio\/192152\/revisions"}],"predecessor-version":[{"id":192162,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/avada_portfolio\/192152\/revisions\/192162"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/media\/192154"}],"wp:attachment":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/media?parent=192152"}],"wp:term":[{"taxonomy":"portfolio_category","embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/portfolio_category?post=192152"},{"taxonomy":"portfolio_skills","embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/portfolio_skills?post=192152"},{"taxonomy":"portfolio_tags","embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/portfolio_tags?post=192152"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}